4baseCare, an innovative healthcare startup focused on closing the significant genomic data gap in cancer care, has successfully raised $6 million (around Rs 50 crore) in its latest funding round.
This investment, spearheaded by Yali Capital, is set to propel 4baseCare’s mission forward. Founded by Hitesh Goswami and Kshitij Rishi, 4baseCare aims to leverage this new capital to significantly enhance its product offerings and broaden its operational reach.
With the funding, 4baseCare plans to accelerate its growth trajectory by scaling its operations across India and expanding into other key markets in Asia and the Middle East.
The company’s advanced solutions in personalized cancer care are designed to offer more precise and effective treatment options, addressing a crucial need in the healthcare sector. By utilizing cutting-edge genomic data, 4baseCare is committed to making high-quality cancer care more accessible to a larger population.
The support from Yali Capital highlights the confidence investors have in 4baseCare’s vision and its potential impact on the future of cancer treatment. As the company continues to innovate and grow, it aims to play a pivotal role in transforming cancer care through enhanced genomic insights and personalized medical solutions.
